Efficacy RENO Study Results of Oral Vinorelbine or Etoposide with Cisplatin Et Chemo-Radiation in Stage III NSCLC. SLCG 10/02

被引：0

作者：

Isla, Dolores ^{[1
]}

De las Penas, Ramon ^{[2
]}

Marse, Raquel ^{[3
]}

Insa Molla, Amelia ^{[4
]}

Martinez-Banaclocha, Natividad ^{[5
]}

Moran, Teresa ^{[6
]}

Mut, Pilar ^{[7
]}

Angeles Sala, Maria ^{[8
]}

Massuti, Bartomeu ^{[9
]}

Ortega Granados, Ana Laura ^{[10
]}

Miguel Jurado, Jose ^{[11
]}

Artal Cortes, Miguel ^{[12
]}

Vazquez, Maria ^{[13
]}

Gutierrez, Vanesa ^{[14
]}

Diz Tain, Pilar ^{[15
]}

Gomez-Codina, Jose ^{[16
,17
]}

Maestu Maiques, Inma ^{[18
]}

Camps, Carlos ^{[19
]}

Vinolas Segarra, Nuria ^{[20
]}

Ponce Aix, Santiago ^{[21
]}

De Mon Soto, Melchor Alvarez ^{[22
]}

Garcia Gomez, Ramon ^{[23
]}

Provencio, Mariano ^{[24
]}

机构：

[1] Univ Hosp Clin Lozano Blesa, Med Oncol, Zaragoza, Spain

[2] Prov Hosp Castellon, Med Oncol, Castellon de La Plana, Spain

[3] Univ Hosp Son Espases, Med Oncol, Palma de Mallorca, Spain

[4] Univ Hosp Clin Valencia, Med Oncol, Valencia, Spain

[5] Gen Univ Hosp Elche, Med Oncol, Elche, Spain

[6] Hosp Badalona Germans Trias & Pujol, Med Oncol, Badalona, Spain

[7] Hosp Son Llatzer, Med Oncol, Palma de Mallorca, Spain

[8] Univ Hosp Basurto, Med Oncol, Bilbao, Spain

[9] Alicante Univ Hosp, Med Oncol, Alicante, Spain

[10] Complejo Hosp Jaen, Med Oncol, Jaen, Spain

[11] Univ Hosp San Cecilio, Med Oncol, Granada, Spain

[12] Univ Hosp Miguel Servet, Med Oncol, Zaragoza, Spain

[13] Univ Hospitality Complex Santiago, Med Oncol, Santiago De Compostela, Spain

[14] Reg Univ Hosp Malaga, Med Oncol, Malaga, Spain

[15] Assistent Complex Leon, Med Oncol, Leon, Spain

[16] Univ Valencia, Med Oncol, Valencia, Spain

[17] Polythecn Hosp La Fe, Valencia, Spain

[18] Univ Hosp Doctor Peset, Med Oncol, Valencia, Spain

[19] Gen Univ Valencia, Consorcio Hosp, Med Oncol, Valencia, Spain

[20] Univ Hosp Clin Barcelona, Med Oncol, Barcelona, Spain

[21] Univ Hosp 12 Octubre, Med Oncol, Madrid, Spain

[22] Univ Hosp Principe Asturias, Med Oncol, Alcala De Henares, Spain

[23] Univ Hosp Gregorio Maranon, Madrid, Spain

[24] Univ Hosp Puerta de Hierro, Med Oncol, Majadahonda, Spain

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期

关键词：

Locally advanced NSCLC; Oral Vinorelbine; chemotherapy; Radiotherapy;

D O I：

10.1016/j.jtho.2016.11.421

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MA06.09

引用

页码：S373 / S374

页数：2

共 43 条

[41] Randomized phase III trial for stage III unresectable non small cell lung (NSCLC) cancer: Induction Chemotherapy (ICT) [vinorelbine (Vr)-cisplatine (P)] followed by conventional radiation (RT) without (arm A) or with daily carboplatin (Cb) (arm B). Final results. Study CRGIBMS/NPC/96 of the French Lung Cancer Study Group FNCLCC and IFCT
Douillard, J
Gervais, R
Quoix, E
Le Chevalier, T
Le Groumellec, A
Lemarie, E
Haller, M
Bardet, E
Lepechoux, C
Henry-Amar, M
LUNG CANCER, 2005, 49 : S16 - S16
[42] Global Lung Oncology Branch trial 3 (Glob 3): final results of a randomised multinational Phase III study of oral and i.v. vinorelbine (NVB) plus cisplatin (CDDP) versus docetaxel (DTX) plus CDDP as first-line treatment for advanced Non-Small Cell Lung Cancer (NSCLC)
Tan, Eng-Huat
Grodzki, Tomasz
Schneider, Claus-Peter
Zatloukal, Peter
Reck, Martin
Aitini, Enrico
Rolski, Janusz
JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S451 - S451
[43] Conventional radiation (RT) with daily carboplatin (Cb) compared to RT alone after induction chemotherapy (ICT) [vinorelbine (Vr)-cisplatine (P)]: Final results of a randomized phase III trial in stage III unresectable non small cell lung (NSCLC) cancer. Study CRG/BMS/NPC/96 of the French Lung Cancer Study Group FNCLCC and IFCT.
Gervais, R
Ducolone, A
Lechevalier, T
Legroumellec, A
Lemarie, E
Quoix, E
Le Pechoux, C
Bardet, E
Henry-Amar, M
Douillard, JY
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 625S - 625S

← 1 2 3 4 5 →